Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan
Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and
Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and
Miami, July 01, 2024 (GLOBE NEWSWIRE) — Miami, FL – July 1st , 2024. Aleph
Copyright © 2026 Cambodia News Service. All rights reserved.